Búsqueda | Biblioteca Virtual en Salud

1.

The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.

Kaplan, G; Kiessling, R; Teklemariam, S; Hancock, G; Sheftel, G; Job, C K; Converse, P; Ottenhoff, T H; Becx-Bleumink, M; Dietz, M.

J Exp Med ; 169(3): 893-907, 1989 Mar 01.

Artículo en Inglés | MEDLINE | ID: mdl-2494293

2.

Short-course instead of long-course chemotherapy for smear-negative patients in sub-Saharan Africa.

van Gorkom, J; van Cleeff, M; Becx-Bleumink, M; Veen, J.

Int J Tuberc Lung Dis ; 5(1): 4-11, 2001 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-11263514

3.

High tuberculosis notification and treatment success rates through community participation in central Sulawesi, Republic of Indonesia.

Becx-Bleumink, M; Wibowo, H; Apriani, W; Vrakking, H.

Int J Tuberc Lung Dis ; 5(10): 920-5, 2001 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-11605885

4.

High cure rates in smear-positive tuberculosis patients using ambulatory treatment with once-weekly supervision during the intensive phase in Sulawesi, Republic of Indonesia.

Becx-Bleumink, M; Djamaluddin, S; Loprang, F; de Soldenhoff, R; Wibowo, H; Aryono, M.

Int J Tuberc Lung Dis ; 3(12): 1066-72, 1999 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-10599009

5.

Evaluation and planning in national tuberculosis control programmes: the usefulness of the standardised patient treatment card.

Ipuge, Y A; Rieder, H L; Becx-Bleumink, M; Kimerling, M E.

East Afr Med J ; 74(12): 816-8, 1997 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-9557430

6.

[The Dutch contribution to worldwide tuberculosis control: Royal Netherlands Association for the Prevention of Tuberculosis (KNCV) Tuberculosis Foundation]. / De Nederlandse bijdrage aan de wereldwijde tuberculosebestrijding: Koninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose (KNCV) Tuberculosefonds.

Becx-Bleumink, M; Gondrie, P C; van Gorkom, J.

Ned Tijdschr Geneeskd ; 147(38): 1875-8, 2003 Sep 20.

Artículo en Neerlandesa | MEDLINE | ID: mdl-14533503

7.

Ziehl-Neelsen staining: strong red on weak blue, or weak red under strong blue?

Angra, P; Becx-Bleumink, M; Gilpin, C; Joloba, M; Jost, K; Kam, K M; Kim, S J; Lumb, R; Mitarai, S; Ramsay, A; Ridderhof, J; Rieder, H L; Selvakumar, N; van Beers, S; van Cleeff, M; Van Deun, A; Vincent, V.

Int J Tuberc Lung Dis ; 11(11): 1160-1, 2007 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-17958975

8.

Multiple drug therapy: implications for field work and training at ALERT (All Africa Leprosy and Rehabilitation Training Centre).

Becx-Bleumink, M.

Lepr Rev ; 57 Suppl 1: 69-80, 1986 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-3586836

9.

Operational aspects of the implementation of multidrug therapy at ALERT, Ethiopia.

Becx-Bleumink, M.

Lepr Rev ; 57 Suppl 3: 115-23, 1986.

Artículo en Inglés | MEDLINE | ID: mdl-3573951

10.

Implementation of multidrug therapy in the ALERT Leprosy Programme in the Shoa Region of Ethiopia. First results with paucibacillary patients.

Becx-Bleumink, M.

Lepr Rev ; 57(2): 111-9, 1986 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-3747703

11.

Comment: 'The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions'.

Becx-Bleumink, M.

Lepr Rev ; 64(3): 281, 1993 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-8231611

12.

Monitoring dapsone self-administration in a multidrug therapy programme.

van Asbeck-Raat, A M; Becx-Bleumink, M.

Lepr Rev ; 57(2): 121-7, 1986 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-3747704

13.

The management of nerve damage in the leprosy control services.

Becx-Bleumink, M; Berhe, D; Mannetje, W.

Lepr Rev ; 61(1): 1-11, 1990 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-2319899

14.

Multiple drug therapy: implications for field work and training at ALERT.

Becx-Bleumink, M.

Ethiop Med J ; 24 Suppl 1: 69-80, 1986 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-3609001

15.

Cotrifazide.

Becx-Bleumink, M.

Indian J Lepr ; 66(1): 69-71, 1994.

Artículo en Inglés | MEDLINE | ID: mdl-7983395

16.

Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.

Becx-Bleumink, M.

Int J Lepr Other Mycobact Dis ; 59(2): 292-303, 1991 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-2071986

17.

Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.

Becx-Bleumink, M.

Int J Lepr Other Mycobact Dis ; 59(4): 558-68, 1991 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-1802938

18.

Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.

Becx-Bleumink, M.

Int J Lepr Other Mycobact Dis ; 60(3): 421-35, 1992 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-1474281

19.

Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.

Becx-Bleumink, M.

Int J Lepr Other Mycobact Dis ; 60(3): 436-44, 1992 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-1474282

20.

Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.

Becx-Bleumink, M.

Int J Lepr Other Mycobact Dis ; 60(2): 161-72, 1992 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-1522358

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.

Short-course instead of long-course chemotherapy for smear-negative patients in sub-Saharan Africa.

High tuberculosis notification and treatment success rates through community participation in central Sulawesi, Republic of Indonesia.

High cure rates in smear-positive tuberculosis patients using ambulatory treatment with once-weekly supervision during the intensive phase in Sulawesi, Republic of Indonesia.

Evaluation and planning in national tuberculosis control programmes: the usefulness of the standardised patient treatment card.

Ziehl-Neelsen staining: strong red on weak blue, or weak red under strong blue?

Multiple drug therapy: implications for field work and training at ALERT (All Africa Leprosy and Rehabilitation Training Centre).

Operational aspects of the implementation of multidrug therapy at ALERT, Ethiopia.

Implementation of multidrug therapy in the ALERT Leprosy Programme in the Shoa Region of Ethiopia. First results with paucibacillary patients.

Comment: 'The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions'.

Monitoring dapsone self-administration in a multidrug therapy programme.

The management of nerve damage in the leprosy control services.

Multiple drug therapy: implications for field work and training at ALERT.

Cotrifazide.

Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.

Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.

Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.

Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.

Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.